 Shares of micro-cap biopharma Vaccinex Inc NASDAQ: VCNX were trading higher Friday on above-average volume. Rochester, New York-based Vaccinex, which focuses on therapies for cancer and neurodegenerative diseases, announced the signing of multiproject deals with two prominent pharma companies that Vaccinex did not identify. 